Active Implants Board

Klyce is a native of Memphis, Tennessee, and has a long and distinguished career in the medical device industry. Most recently, he was the founder, president/CEO and chairman of St. Francis Medical Technologies, a privately held company that developed and marketed the X STOP Interspinous Process Decompression System. In January 2007, Kyphon Inc. (NASDAQ: KYPH) acquired St. Francis for $725 million (Kyphon was later acquired by Medtronic Inc, NYSE: MDT). Prior to St. Francis, Klyce started and built several successful medical device companies in ophthalmics, neurosurgery and orthopedics. Klyce has a bachelor’s degree from Cornell University and is an inventor with over 30 issued patents.

Ted Davis has 25 years of experience in the life sciences industry as an investor and senior executive, including chief executive officer of MicroPort Orthopedics and president of its predecessor Wright Medical Technology’s global OrthoRecon division from 2012 through 2015. Prior to leading the carve out and integration of the OrthoRecon platform, Davis led Wright’s business development, corporate development and research & development functions from 2006 to 2012, with increasing responsibility for the business development, government affairs, national accounts, reimbursement, medical education and global research & development teams. Davis oversaw the acquisition and integration of a series of extremities and biologics platforms during Wright’s transformation into the market leader in the extremities market segment. Prior to joining Wright in 2006, Davis spent 10 years in the life sciences venture capital field, serving on the boards of multiple biotechnology and medical device companies while at MB Venture Partners and Vector Fund Management. He holds an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree in engineering from Vanderbilt University.

Federico has 44 years of experience in the medical device industry, with significant focus in the sports medicine segment while president and chief executive officer of Orthofix International N.V. and president of Smith & Nephew Endoscopy. Additionally, he has held senior management and sales and marketing positions with Dyonics, General Foods Air Products Corporation, Puritan Bennett Corporation and LSE Corporation. Federico has extensive board experience, including chairman of the board and lead director of MAKO Surgical Corp, sold to Stryker; and a board member at Biomimetic Therapeutics, sold to Wright Medical Group.

Henley has more than 35 years of experience in the orthopedic device industry, including president, chief executive officer and board member of United Orthopedic Group, which was sold to Breg.  Previously, he was president and chief executive officer of Wright Medical Group, Inc.; president of Orthofix International N.V.’s Americas Division; president of Smith & Nephew’s Endoscopy Video Division; and president and chief executive officer of Cecorp, Inc. Henley is an experienced board member and industry consultant, most recently serving as executive chairman of the board of directors at OrthAlign, Inc. and a director at Orchid Orthopedic Solutions.

Lackie has been involved in venture capital and private equity investing during the last 30 years. He started his career in commodities futures trading with Cook Industries, Dunavant Enterprises, Refco, and Lackie Trading Inc. Now active in private equity investments, Lackie has served as a director, consultant, board observer and officer of start-up and later-stage companies in retail, insurance, medical devices, rugged PDAs, real estate, and identity theft protection. He actively manages holdings in various hedge funds, and is president of River Street Management Company, an advisory and management services company. He also serves on the board of trustees of the Campbell Foundation and the University of Memphis Foundation. Lackie is a graduate in finance (cum laude) from the University of Memphis.

Mays concentrates his practice in the areas of taxation, business organizations, estate planning, and business and commercial law transactions. He is listed in the Best Lawyers in America in corporate, mergers and acquisitions and securities law. Mays received a bachelor of business administration from the University of Mississippi at Oxford, a juris doctorate from Vanderbilt University School and a master of laws in taxation from New York University School.

Wilson is a principal of Kemmons Wilson Companies. He is actively involved in the private investments initiative. His primary focus is to seek out, analyze and recommend investment opportunities, particularly operating businesses. Additionally, he has oversight responsibilities for the Family of Orange Lake Resorts headquartered in Orlando, Florida. He works closely with that company’s senior leadership on a variety of operational functions, management development and the creation of long-term strategies. Currently, Spence is on several other professional boards, including Kemmons Wilson Insurance Group and Innova. Philanthropic/civic boards include the National Civil Rights Museum, the Memphis Chairman’s Circle, the Memphis Chamber of Commerce, the FedEx/St. Jude Classic and Cordaid. Wilson received a bachelor’s degree in commerce & business administration from the University of Alabama and a master’s of business administration from the University of Memphis.